Characterization of dicalcium phosphate dihydrate cements prepared using a novel hydroxyapatite-based formulation

Dicalcium phosphate dihydrate (DCPD) cements are typically prepared using β-tricalcium phosphate (β-TCP) as the base component. However, hydroxyapatite (HA) is an interesting alternative because of its potential for reducing cement acidity, as well as modulating cement properties via ionic substitutions. In the present study, we have characterized DCPD cements prepared with a novel formulation based on monocalcium phosphate monohydrate (MCPM) and HA. Cements were prepared using a 4:1 MCPM:HA molar ratio. The reactivity of HA in this system was verified by showing DCPD formation using poorly crystalline HA, as well as highly crystalline HA. Evaluation of cements prepared with poorly crystalline HA revealed that setting occurs rapidly in the MCPM/HA system, and that the use of a setting regulator is necessary to maintain workability of the cement paste. Compressive testing showed that MCPM/HA cements have strengths comparable to what has previously been published for DCPD cements. However, preliminary in vitro analysis of cement degradation revealed that conversion of DCPD to HA may occur much more rapidly in the MCPM/HA system compared to cements prepared with β-TCP. Future studies should investigate this property further, as it could have important implications for the use of HA-based DCPD cement formulations.

[1]  M. Bohner.  Reactivity of calcium phosphate cements , 2007 .

[2]  D. Farrar,et al.  Brushite Cements from Polyphosphoric Acid, Calcium Phosphate Systems , 2007 .

[3]  L. Brečević,et al.  Precipitation of calcium phosphates from electrolyte solutions V. The influence of citrate ions , 1979, Calcified Tissue International.

[4]  J. Metz,et al.  Bovine albumin release and degradation analysis of dicalcium phosphate dihydrate cement. , 2006, Biomedical sciences instrumentation.

[5]  D. Farrar,et al.  Cement from nanocrystalline hydroxyapatite: Effect of calcium phosphate ratio , 2005, Journal of materials science. Materials in medicine.

[6]  L. Grover,et al.  Cement Formulations in the Calcium Phosphate H2O-H3PO4-H4P2O7 System , 2005 .

[7]  M. Bohner,et al.  Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment. , 2005, Biomaterials.

[8]  F. Carceller,et al.  Clinical applications of Norian SRS (calcium phosphate cement) in craniofacial reconstruction in children: our experience at Hospital La Paz since 2001. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[9]  L. Grover,et al.  Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement. , 2004, Biomaterials.

[10]  U Gbureck,et al.  Cements from nanocrystalline hydroxyapatite , 2004, Journal of materials science. Materials in medicine.

[11]  M Bohner,et al.  In vivo behavior of three different injectable hydraulic calcium phosphate cements. , 2004, Biomaterials.

[12]  L. Grover,et al.  Ionic modification of calcium phosphate cement viscosity. Part II: hypodermic injection and strength improvement of brushite cement. , 2004, Biomaterials.

[13]  J C Knowles,et al.  In vitro ageing of brushite calcium phosphate cement. , 2003, Biomaterials.

[14]  M. Bohner,et al.  Compositional changes of a dicalcium phosphate dihydrate cement after implantation in sheep. , 2003, Biomaterials.

[15]  E. Schneider,et al.  Resorption patterns of calcium-phosphate cements in bone. , 2003, Journal of biomedical materials research. Part A.

[16]  G. Cressey,et al.  The effect of organic ligands on the crystallinity of calcium phosphate , 2003 .

[17]  M. Bohner,et al.  Compositional changes of a brushite hydraulic cement after implantation in sheep , 2003 .

[18]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[19]  J. Déjou,et al.  The biodegradation mechanism of calcium phosphate biomaterials in bone. , 2002, Journal of biomedical materials research.

[20]  A. Parhiscar,et al.  BoneSource for Craniomaxillofacial Reconstruction , 2000, Facial plastic surgery : FPS.

[21]  E. Fernández,et al.  Calcium phosphate bone cements for clinical applications. Part II: Precipitate formation during setting reactions , 1999, Journal of materials science. Materials in medicine.

[22]  E. Fernández,et al.  Calcium phosphate bone cements for clinical applications. Part I: Solution chemistry , 1999, Journal of materials science. Materials in medicine.

[23]  S. Goodman,et al.  Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. , 1998, Journal of biomedical materials research.

[24]  P. Brown,et al.  Hydrolysis of dicalcium phosphate dihydrate to hydroxyapatite , 1998, Journal of materials science. Materials in medicine.

[25]  M. Bohner,et al.  Composition effects on the pH of a hydraulic calcium phosphate cement , 1997, Journal of materials science. Materials in medicine.

[26]  J. Lemaître,et al.  Optimization of setting time and mechanical strength of beta-TCP/MCPM cements , 1997 .

[27]  J. Elliott,et al.  Structure and chemistry of the apatites and other calcium orthophosphates , 1994 .

[28]  J. Lemaître,et al.  Calcium phosphate cements: study of the beta-tricalcium phosphate--monocalcium phosphate system. , 1989, Biomaterials.

[29]  L. Chow,et al.  Calcium Phosphate Materials: Reactor Response , 1988, Advances in dental research.

[30]  W. E. Brown,et al.  Basic Biological Sciences Hydrolysis of Dicalcium Phosphate Dihydrate in the Presence or Absence of Calcium Fluoride , 1985, Journal of dental research.

[31]  G. H. Nancollas,et al.  Kinetics of crystal growth of dicalcium phosphate dihydrate , 1969 .